Showing results (221-230 of 756) with videos related to
Sort By:
Pageof 76
Trends in Microbiology|July 1, 2023
SARS-CoV-2 and the spike protein in endotheliopathyLuca Perico, Ariela Benigni, Giuseppe RemuzziKidney International Supplements|August 28, 2015
Key fibrogenic mediators: old players. Renin-angiotensin systemDaniela Macconi, Giuseppe Remuzzi, Ariela BenigniNephron. Clinical Practice|November 28, 2014
Rituximab in primary membranous nephropathy: first-line therapy, why not?Paolo Cravedi, Giuseppe Remuzzi, Piero RuggenentiNature Reviews. Nephrology|July 1, 2018
The role of B7-1 in proteinuria of glomerular originRubina Novelli, Ariela Benigni, Giuseppe RemuzziCurrent Opinion in Pharmacology|April 30, 2017
New biologics in the treatment of rare glomerular diseases of childhoodPaolo Cravedi, Andrea Angeletti, Giuseppe RemuzziPediatric Nephrology (Berlin, Germany)|June 28, 2018
Autoimmune abnormalities of the alternative complement pathway in membranoproliferative glomerulonephritis and C3 glomerulopathyMarina Noris, Roberta Donadelli, Giuseppe RemuzziKidney International|May 29, 2020
The case of complement activation in COVID-19 multiorgan impactMarina Noris, Ariela Benigni, Giuseppe RemuzziPharmacological Research|March 17, 2024
Efficacy of erythropoietin as a neuroprotective agent in CKD-associated cognitive dysfunction: A literature systematic reviewMichelangela Barbieri, Paolo Chiodini, Piergiacomo Di Gennaro, et al.American Journal of Disaster Medicine|March 2, 2019
Disaster medicine and response: Optimizing life-saving potentialMehmet Sukru Sever, Giuseppe Remuzzi, Raymond VanholderJournal of the American Society of Nephrology : JASN|December 19, 2008
Liver-kidney transplantation to cure atypical hemolytic uremic syndromeJeffrey M Saland, Piero Ruggenenti, Giuseppe Remuzzi, et al.Pageof 76